Evidence map›Paper›PMID 37948866›Full record

SynthesisEnvironment international2023

Systematic evidence mapping informs a class-based approach to assessing personal care products and pubertal timing.

Kyla W Taylor, Kembra L Howdeshell, Paige A Bommarito, Christopher A Sibrizzi, Robyn B Blain, Kristen Magnuson, Courtney Lemeris, Wren Tracy, Donna D Baird, Chandra L Jackson and 4 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Environment international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Environmental factors trigger pubertal development.Current opinion in pediatrics · 2025
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Kyla W TaylorNational Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA. Electronic address: kyla.taylor@nih.gov.
Kembra L HowdeshellNational Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA.
Paige A BommaritoNational Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA.
Christopher A SibrizziICF, Reston, VA, USA.
Robyn B BlainICF, Reston, VA, USA.
Kristen MagnusonICF, Reston, VA, USA.
Courtney LemerisICF, Reston, VA, USA.
Wren TracyICF, Reston, VA, USA.
Donna D BairdNational Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA.
Chandra L JacksonNational Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA; National Institute on Minority Health and Health Disparities, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
Symielle A GastonNational Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA.
Cynthia V RiderNational Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA.
Vickie R WalkerNational Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA.
Andrew A RooneyNational Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA.
National Institute of Environmental Health Sciences · USICF International (United States) · USNational Institute on Minority Health and Health Disparities · US

Funding

Consumer Products and Therapeutics Research ProgramZIAES103379 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI TAYLOR, KYLA · 2022 to 2025
$9.9M
Intramural NIH HHS Z99 ES999999Intramural NIH HHS ZIA ES103379
6 · The paper itself

Abstract

backgroundPersonal care products (PCPs) contain many different compounds and are a source of exposure to endocrine disrupting chemicals (EDCs), including phthalates and phenols. Early-life exposure to EDCs commonly found in PCPs has been linked to earlier onset of puberty.

objectiveTo characterize the human and animal evidence on the association between puberty-related outcomes and exposure to PCPs and their chemical constituents and, if there is sufficient evidence, identify groups of chemicals and outcomes to support a systematic review for a class-based hazard or risk assessment.

methodsWe followed the OHAT systematic review framework to characterize the human and animal evidence on the association between puberty-related health outcomes and exposure to PCPs and their chemical constituents.

resultsNinety-eight human and 299 animal studies that evaluated a total of 96 different chemicals were identified and mapped by key concepts including chemical class, data stream, and puberty-related health outcome. Among these studies, phthalates and phenols were the most well-studied chemical classes. Most of the phthalate and phenol studies examined secondary sex characteristics and changes in estradiol and testosterone levels. Studies evaluating PCP use and other chemical classes (e.g., parabens) had less data.

conclusionsThis systematic evidence map identified and mapped the published research evaluating the association between exposure to PCPs and their chemical constituents and puberty-related health outcomes. The resulting interactive visualization allows researchers to make evidence-based decisions on the available research by enabling them to search, sort, and filter the literature base of puberty-related studies by key concepts. This map can be used by researchers and regulators to prioritize and target future research and funding to reduce uncertainties and address data gaps. It also provides information to inform a class-based hazard or risk assessment on the association between phthalate and phenol exposures and puberty-related health outcomes.

Indexed as

Endocrine DisruptorsPhthalic AcidsAnimalsEnvironmental ExposureHumansPhenolPhenolsSexual MaturationEndocrine DisruptorsPhenolPhenolsphthalic acidPhthalic AcidsChemical classPersonal care productsPhenolsPhthalatesPubertySystematic evidence map

Identifiers

PMID37948866
PMCPMC12368981
OpenAlexW4388336922

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.